These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6127893

  • 1. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA, Evenson MK, Needham KE, Mason DT.
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA, Needham KE, Evenson MK, Win A, Mason DT.
    Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
    [Abstract] [Full Text] [Related]

  • 3. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R, Meyer J, Schweizer P, Lambertz H, Voelker W, Effert S.
    Acta Med Scand Suppl; 1982 Feb; 659():169-80. PubMed ID: 6127887
    [Abstract] [Full Text] [Related]

  • 4. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD, Qing LG, Olivari MT, Fiorentini C, Loaldi A, Bartorelli A, Moruzzi P, Polese A.
    Acta Med Scand Suppl; 1982 Feb; 659():233-50. PubMed ID: 6127892
    [Abstract] [Full Text] [Related]

  • 5. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
    Kupper W, Schütt M, Bleifeld W.
    Acta Med Scand Suppl; 1982 Feb; 659():287-98. PubMed ID: 6127895
    [Abstract] [Full Text] [Related]

  • 6. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
    Doering W, Wauer B, Isbary J.
    Acta Med Scand Suppl; 1982 Feb; 659():307-14. PubMed ID: 6127897
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
    Klein W, Brandt D, Maurer E.
    Clin Cardiol; 1981 Feb; 4(6):325-9. PubMed ID: 6120057
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
    Leinberger H, Mäurer W, Haueisen H, Schuler G, Kübler W.
    Acta Med Scand Suppl; 1982 Feb; 659():299-306. PubMed ID: 6127896
    [Abstract] [Full Text] [Related]

  • 9. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
    Branzi A, Specchia S, Binetti G, Magelli C, Zannoli R, Magnani B.
    Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
    [Abstract] [Full Text] [Related]

  • 10. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W, Schütt M, Hamm CW, Kuck KH, Hanrath P, Bleifeld W.
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
    Tweddel AC, Murray RG, Pearson D, Martin W, Hutton I.
    Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
    [Abstract] [Full Text] [Related]

  • 12. Effects of prenalterol administered orally in patients with congestive heart failure.
    Hjalmarson A, Abelardo N, Caidahl K, Reyes C, Waagstein F, Wallentin I, Wikstrand J, Estrada-Yamamoto M.
    Acta Med Scand Suppl; 1982 Apr; 659():201-20. PubMed ID: 6127890
    [Abstract] [Full Text] [Related]

  • 13. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
    Andersson T, Heath A, Mattsson H.
    Acta Med Scand Suppl; 1982 Apr; 659():71-88. PubMed ID: 6127900
    [No Abstract] [Full Text] [Related]

  • 14. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA, Oltmanns D.
    Acta Med Scand Suppl; 1982 Apr; 659():181-90. PubMed ID: 6127888
    [Abstract] [Full Text] [Related]

  • 15. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S, Høilund-Carlsen PF, Hesse B, Hartling OJ, Fabricius J, Dige-Petersen H, Giese J.
    Eur J Clin Pharmacol; 1984 Apr; 27(5):539-43. PubMed ID: 6151507
    [Abstract] [Full Text] [Related]

  • 16. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
    Drexler H, Löllgen H, Just H.
    Acta Med Scand Suppl; 1982 Apr; 659():315-24. PubMed ID: 6127898
    [No Abstract] [Full Text] [Related]

  • 17. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
    Svendsen TL, Carlsen JE, Hartling OJ, Trap-Jensen J.
    Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
    [Abstract] [Full Text] [Related]

  • 18. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
    Waagstein F, Estrada-Yamamoto M, Reiz S, Reyes C, Hjalmarson A.
    Acta Med Scand Suppl; 1982 Oct; 659():221-31. PubMed ID: 6127891
    [Abstract] [Full Text] [Related]

  • 19. Clinical results with prenalterol in patients with heart failure.
    Waagstein F, Reiz S, Ariniego R, Hjalmarson A.
    Am Heart J; 1981 Sep; 102(3 Pt 2):548-54. PubMed ID: 7270401
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
    Svendsen TL, Pelle H, Lønholt C, Bonde J, Kampmann JP, Lindeneg O.
    J Cardiovasc Pharmacol; 1984 Sep; 6(4):693-6. PubMed ID: 6206327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.